SD in Subjects With T2DM.
Phase of Trial: Phase I
Latest Information Update: 04 Jul 2014
At a glance
- Drugs JNJ 38431055 (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Janssen Research & Development
- 01 Aug 2012 Results published in the Diabetes, Obesity and Metabolism.
- 09 Dec 2009 Actual patient number (25) added as reported by ClinicalTrials.gov.
- 29 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History